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Available online 4 May 2011In the present research the role of gender in MDMA-induced hyperthermia and serotonin
depletion is studied by injecting male and female male rats with MDMA or saline 3 times (i.
p.) with 3 h interval at dosages of 0.3, 1, 3 or 9 mg/kg at an ambient temperature of 25 °C. The
acute hyperthermia following the higher dosages was much stronger in males than in
females. After the highest dose, body temperature was even raised for several days. This
effect was particularly present in males where nocturnal hyperthermia persisted the whole
4-week period of sampling. Despite the differences in the acute hyperthermic response, no
significant gender differences were found in 5-HT depletion 4 weeks after MDMA (9 mg/kg)
administration. A striking difference was present, however, in the concentration of the 5-HT
metabolite 5-HIAA after MDMA administration. In males 5-HIAA levels decreased, whereas
in females this metabolite was hardly affected, suggesting a lasting increase in 5-HT
turnover in females following drug administration. When genders were matched for their
acute physiological hyperthermic response by repeated injection of 9 mg/kg in female rats
and 6 mg/kg in male rats, 5-HT depletion was only present in females. In this experiment
with matched acute physiological responses 5-HIAA levels also decreased much stronger in
males, suggesting an increased 5-HT turnover in females 4 weeks after MDMA
administration. In conclusion, although male rats are clearly more susceptible for the
acute as well as the lasting hyperthermic effects of MDMA than females, this is not reflected
in levels of 5-HT depletion following administration of similar dosages of the drug. This may
indicate that, in case of a similar thermogenic response, females have a higher 5-HT
neurotoxicity following MDMA than males.
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Fig. 1 – (a) Average total body temperature (±SEM) response
measured as area under the curve (AUC) over the first 9 h
after the first MDMA injection. Male and female rats were
injected 3×0.3, 3×1, 3×3 or 3×9 mg/kg MDMA or saline.
*p<0.05, difference between males and females treated with
similar doses. (b) Average body temperature (±SEM) of male
and female rats over time. Rats were injected three times
with 0 or 9 mg/kg MDMA. Injections were administered at
time points 0, 3 and 6 h. Arrows indicated time of injection.
**p<0.01, comparison between male and female peak
responses following 3×9 mg/kg MDMA.
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Another reason for concern is the long-lasting, possibly
neurotoxic consequences of MDMA for the serotonergic
system. Several preclinical studies have demonstrated
that MDMA evokes a persistent decrease in serotonin and
5-hydroxyindoleacetic acid (5-HIAA), a reduction in trypto-
phan hydroxylase (TPH) activity, a reduction of serotonin
transporter (SERT) activity and expression and finally a long-
term impairment of anterograde transport in serotonin axons
(Battaglia et al., 1987; Buchert et al., 2004; Callahan et al., 2001;
Colado et al., 1993; Hewitt and Green, 1994; Ricaurte et al., 2000;
Schmidt and Taylor, 1987; Semple et al., 1999; Sharkey et al.,
1991; Stone et al., 1986; Xie et al., 2006). Although clinical studies
on this matter are less conclusive, there is increasing evidence
that MDMA can be toxic for the human brain too. (deWin et al.,
2004; Grob, 2002; McCann et al., 2000; Turner and Parrott, 2000).
In preclinical psychopharmacological research females are
often not included because of the hormonal fluctuations due
to the estrous cycle. However, preclinical and clinical studies
emphasize the importance of sex differences in the pharma-
cokinetic and pharmacodynamic responses to many drugs of
abuse, including alcohol, nicotine and psychostimulants like
cocaine and amphetamine (Becker et al., 2001; Brady and
Randall, 1999; Carroll et al., 2004; Lynch et al., 2002).
In view of the fact that the use of ecstasy increased
significantly among females together with the high popularity
of ecstasy (Allott and Redman, 2007) it is important to consider
gender as a modulatory factor in the long-lasting effects of
MDMA on serotonergic functioning. Therefore, the present
study aimed at the question of gender differences in the long-
lasting serotonergic neurotoxic consequences.
Data from studies in humans do suggest a gender
difference. Females seem to be more susceptible than males
to deficiencies in 5-HT functioning after ecstasy use (Buchert
et al., 2004; Croft et al., 2001; McCann et al., 1994; Reneman et
al., 2001). Furthermore, it was shown that equal doses of
MDMAper kilogram bodyweight produced stronger subjective
effects in women compared to men (Liechti et al., 2001).
So far, animal studies have found no (consistent) difference
betweenmale and female rats in depletion of 5-HT and 5-HIAA
levels after MDMA administration (Chu et al., 1996; Koenig et
al., 2005; Walker et al., 2007). Regarding gender differences in
MDMA-induced changes in body temperature and behavioral
locomotor response, conflicting results are reported (Colado et
al., 1995; Fonsart et al., 2008; Koenig et al., 2005; Palenicek et al.,
2005; Walker et al., 2007; Wyeth et al., 2009).
The present study investigated whether male and female
rats differ in the acute hyperthermic and long-term body
temperature regulation in response to MDMA administration
and in the 5-HT depleting effects of the drug. The study was
divided into two experiments. In the first experiment it was
investigated whether there are differences in acute and long-
term body temperature effects and in the long-term seroto-
nergic depletion between male and female rats after MDMA
administration. Different dosages of MDMA were adminis-
tered and the MDMA-induced hyperthermic response was
measured in both males and females. Body temperature was
measured using biotelemetry, to assure body temperature
sampling in a stress-free manner. To control for interaction
effects with body temperature, in a second experiment maleand female rats were matched for their acute MDMA-induced
hyperthermic peak response and it was investigated whether
thesemale and female rats differed in the long-term serotonin
depletion.2. Results
2.1. Experiment 1
2.1.1. Acute effect of MDMA on body temperature
In Fig. 1a the AUC is plotted for the temperature response
between 0 and 9 h after three injections of MDMA in different
doses. MDMA induced a significant hyperthermic response in
rats administered 3×9 mg/kgMDMA (main dose effect F(4,47)=
30.954, p<0.0001). When taking also gender into account, the
two-factor ANOVA revealed a significant gender×dose inter-
action effect (F(4,47)=8.388, p<0.0001). The dynamics of the
temperature response in male and female rats following
administration of the highest dose is visualized in Fig. 1b. As
shown in Fig. 1a and b, the hyperthermic response was
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Fig. 2 – Average body temperature (±SEM) of male and female
rats per 12 h during 28 days. At day zero repeated MDMA
(3×9 mg/kg) or saline injections were given. Light symbols in
the upper graph represent the average body temperature
during the light phase. Dark symbols in the lower graph
represent the average body temperature during the dark
phase. **p<0.01, comparison with saline treated controls;
#p<0.05, ##p<0.01, comparison between MDMA treated
males and females.
15B R A I N R E S E A R C H 1 3 9 8 ( 2 0 1 1 ) 1 3 – 2 0p<0.001). The dose of 3×3 mg/kg MDMA only induced a
significant hyperthermic response in males (F(4,23)=112.179,
p<0.0001.
2.1.2. Lethality
Since the highest dose (3×9 mg/kg) elicited a strong hyper-
thermic response in particular inmale rats this was coinciding
with a high lethality in the male animals. Out of 15 male rats
being administered with 3×9 mg/kg only 6 survived (survival
rate 40%), while out of 9 female rats injected with 3×9 mg/kg
8 rats survived (survival rate 89%). Employing logistic regres-
sion using themodel Y=LOG (p/(p−1)=ax+b (p=chance of a rat
dying and a zero model was used for fit, with y=constant)
revealed that dosage (X2=30.88, p<0.0001) of MDMA and
gender (X2=6.13, p<0.05) together determined survival rate,
indicating that significantly more males than females died
after receiving 3×9 mg/kg MDMA.
2.1.3. Long-term effect on body temperature
Also on the long-term, MDMA treatment resulted in a
differential body temperature response in male and female
rats. A significant main effect of gender (F(1,19)=8.0; p=0.01)
and treatment (F(1,19)=12.9; p=0.002) was present in temper-
atures during the day, although there was no significant
interaction between gender and treatment. Comparison of the
night temperatures did show, however, a significant interac-
tion between gender and treatment (F(1,19)=16.9; p=0.001).
Post hoc analysis revealed that female rats receiving 3×9 mg/
kg MDMA were hyperthermic during the light phase 1 day
after repeated MDMA treatment, whereas male rats stayed
hyperthermic during the light phase until day 3 after MDMA
administration (see Fig. 2). MDMA treatment of 3×9 mg/kg in
male rats increased body temperature during the dark phase
(active period of the day) for the whole registration period as
compared to female rats treated with the drug. Actually
MDMA in 3×9 mg/kg dose tended to suppress body temper-
ature during the night in the female rats.
2.1.4. Monoamine concentrations
Monoamine concentrations were measured in the following
8 brain regions: prefrontal cortex, hippocampus, parietal
cortex, septum, cerebellum, brainstem, hypothalamus and
striatum. The direction of changes was similar in all brain
regions, although local differences existed in themagnitude of
the observed changes. For an easy interpretation of the data
we therefore restricted the graphical visualization of the data
to only 3 brain regions: prefrontal cortex (PFC), hippocampus
and striatum.
MDMA (3×9 mg/kg) clearly induced 5-HT depletion in these
three brain areas (main treatment effect, F(3,26) =27.6;
p<0.001). There was an effect of gender (F(3,26)=2.9; p=0.052)
but male and female rats did not significantly differ in the
induced 5-HT depletion (no significant treatment×gender
interaction (Fig. 3a).
MDMA evoked a depletion in the serotonergicmetabolite 5-
HIAA in all three brain areas (main treatment effect, F(3,26)
=28.1, p<0.001). When gender was also taken into account, a
significantly larger 5-HIAA depletion was found in the
hippocampus of male rats compared to female rats (treat-
ment×gender interaction (F(1,28)=7.9, p<0.01) (Fig. 3b). Posthoc testing showed that 5-HIAA levels in the prefrontal cortex
and hippocampus were significantly higher in MDMA treated
females than in MDMA treated males (p<0.05 and p<0.001,
respectively).
MDMA did not induce a depletion of DA, DOPAC, HVA and
NA levels in any of themeasured brain areas (data not shown).
2.2. Experiment 2
The results of experiment 1 showed that MDMA induced a
significantly higher acute hyperthermia in males than in
females and that this did not coincide with sex differences in
serotonin depletion in the brain. As explained in the Exper-
imental procedures, in a subsequent experiment we aimed to
match males and female for their hyperthermic response to
MDMA and investigated the long-term effect on the seroto-
nergic system in the brain. For this purpose we added a group
of male rats that were injected with 3×6 mg/kg MDMA. This
dose in males induced a hyperthermia that matched the
Fig. 3 – Average (a) 5-HT and (b) 5-HIAA tissue concentration
(±SEM) as measured in prefrontal cortex (PFC), hippocampus
and striatum of male and female rats, 4 weeks after repeated
saline or MDMA injections (3×9 mg/kg). *p<0.05, **p<0.01,
comparison between MDMA treated rats and vehicle treated
controls; #p<0.05, ##p<0.01, comparison between MDMA
treated males and females.
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Fig. 4 – (a) Average total body temperature (±SEM) response
measured as area under the curve (AUC) over the first 9 h
after the first MDMA injection. Female rats were injected
three timeswith 0 or 9 mg/kgMDMA.Male rats were injected
three times with 0 or 6 mg/kg. *p<0.05, difference between
males and females. (b) Average body temperature (±SEM) of
male and female rats over time. Female rats were injected
three timeswith 0 or 9 mg/kgMDMA.Male rats were injected
three times with 0 or 6 mg/kg. Injections were administered
at time points 0, 3 and 6 h. Arrows indicated time of injection.
16 B R A I N R E S E A R C H 1 3 9 8 ( 2 0 1 1 ) 1 3 – 2 0hyperthermia in female rats that were injected with 3×9 mg/
kg MDMA as indicated in Fig. 4. Although the AUC measure-
ments (see Fig. 4a) of the temperature following drug
administration show that in male rats, even with a lower
dose of 6 mg/kg, the overall acute hyperthermic response was
still larger than that in females after 9 mg/kg MDMA, no
general gender difference existed in peak temperatures
(Fig. 1b). Since in experiment 1 MDMA only resulted in a
depletion of 5-HT and 5-HIAA concentrations, DA, DOPAC,
HVA and NA concentrations were not analyzed.
2.2.1. 5-HT and 5-HIAA analysis
Statistical analysis revealed that MDMA induced a significant
depletion in 5-HT concentrations in the three brain areas
(main treatment effect, F(3,30)=10.6, p<0.001). Similar to
experiment 1, the magnitude of the 5-HT depletion did not
differ between both genders (Fig. 5a). Post hoc analysis
revealed that MDMA induced only in females a 5-HT depletion
in the PFC and hippocampus (Fig. 5a).
MDMA induced also a 5-HIAA depletion (main treatment
effect F(3,30)=22.3, p<0.001). There also was a main effect of
gender (F(3,30)=12.7; p<0.001). Post hoc analysis revealed that
5-HIAA significantly dropped in all male brain regions after
6 mg/kg MDMA and that in the prefrontal cortex and
hippocampus 5-HIAA levels were also significantly lower
than in females treated with 9 mg/kg MDMA (Fig. 5b).Fig. 5 – Average (a) 5-HT and (b) 5-HIAA tissue concentration
(±SEM) as measured in prefrontal cortex (PFC), hippocampus
and striatum of male and female rats, 4 weeks after repeated
saline or MDMA injections (3×9 mg/kg in female rats and
3×6 mg/kg in male rats). *p<0.05, **p<0.01, comparison
between MDMA treated rats and vehicle treated controls;
##p<0.01, comparison between MDMA treated males and
females.
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The present study aimed to reveal gender differences in the
acute and lasting effects on temperature regulation and
monoamine depletion after MDMA treatment, using several
dosages of MDMA. MDMA induced a much stronger acute
hyperthermic response in male rats compared to female rats
following treatment with 3×9 mg/kg MDMA which coincided
with a higher lethality rate. This indicates that male rats are
more vulnerable for the acute hyperthermic and lethal effects
of MDMA than female rats. Our finding is in agreement with
previous studies (Fonsart et al., 2008; Koenig et al., 2005;Wyeth
et al., 2009). Furthermore, the lasting increase in body
temperature during the night time that was observed only in
male rats receiving the highest dose of MDMA indicates that
male rats are also more vulnerable for long-lasting changes in
temperature regulating mechanisms than female rats.
It is well known that the MDMA-induced long-term
depletion of 5-HT and 5-HIAA tissue concentrations is related
to the presence of an acute MDMA-induced hyperthermic
response (Dafters, 1994; Malberg and Seiden, 1998). When the
acute hyperthermia is absent, 5-HT depletion is abolished or
attenuated (Broening et al., 1995; Colado et al., 1998; Farfel and
Seiden, 1995; Malberg et al., 1996; O'Shea et al., 2002).
Therefore, it was surprising to notice that, despite the
differences in hyperthermic responses, male and female rat
did not differ in the magnitude of the MDMA-induced 5-HT
depletion. Another striking observation was that 5-HIAA
depletion was only observed in males. It is well known that
MDMA is able to inhibit MAO-A activity (Leonardi and Azmitia,
1994). It is possible that MDMA inhibits MAO-A enzyme
activity to a greater extent in males than in females, inducing
only a significant depletion of 5-HIAA concentrations in male
rats. Furthermore, it can be hypothesized that due to gender
differences in the 5-HT system in the medial preoptic nucleus
(Simerly et al., 1984) which possibly includes MAO-A enzyme
activity, that MDMA administration induces a stronger
inhibition of MAO-A activity causing a higher extracellular 5-
HT release in male rats and therefore inducing a greater
hyperthermic response. Another possible explanation for the
higher hyperthermic response in males may be found in the
effects of the metabolite of MDMA, MDA, which causes a
stronger hyperthermic peak response in males than in
females (Fonsart et al., 2008). Since MDMA seems to be
metabolized stronger in male than in female rats resulting in
higher MDA levels in the male rats (Fonsart et al., 2008), the
higher plasmaMDA levels might play an important role in the
stronger hyperthermia in male rats.
Since the temperature response differed so strongly
between the genders we added a group of male rats receiving
a lower dose of MDMA that would match the peak tempera-
tures reached in females using the highest dose. In female rats
having similar peak temperature responses as males, 5-HT
decreased significantly, whereas concentration of 5-HT was
not significantly decreased in males.
There is a circadian rhythmicity in body temperature
regulation with temperatures being higher during the active
period of the day (which is the dark phase for nocturnal
animals like rats) and lower during the inactive period (lightphase) of the day. For several days after MDMA treatment,
particularly in males the body temperature is higher in the
light phase than in the dark phase. This might indicate that
MDMA induces a temporal shift in circadian rhythmicity.
Indeed, there is evidence indicating that MDMA can induce
abnormalities in sleep and circadian patterns (Balogh et al.,
2004; McCann and Ricaurte, 2007) in humans and rodents.
A number of points for consideration come up with regard
to the performed experiment. Firstly, mortality rates show
that 2/3 of the males died after receiving 3×9 mg/kg MDMA.
This may have caused a bias in the interpretation of the
outcome of the monoamine analysis. It is possible that the
male rats that died after the MDMA injections are the rats that
would also have the largest 5-HT depletion. The surviving rats
might be relatively resistant to the MDMA-induced 5-HT
depletion. If this would be true, it would result in an
underestimation of the serotonergic depletion in males that
received 3×9 mg/kg MDMA and a biased conclusion regarding
the possible gender differences in vulnerability for MDMA-
induced neurotoxicity. Importantly, after administration of
3×6 mg/kgMDMA tomale rats all rats survived, resulting in an
unbiased gender comparison.
Another point of concern may be the difference in body
weight betweenmales and females and sex-linked differences
in pharmacokinetics. In general adult male rats are heavier
than females (in the present study about 160 g difference).
Since MDMA is administered in a dose per kg body weight the
injected total amount of MDMA is therefore higher in males
than in females. There are, however, extensive pharmacoki-
netic studies available comparing gender effects in male and
female rats (Chu et al., 1996; Fonsart et al., 2008; Fonsart et al.,
2009; Hirt et al., 2010). These studies all clearly indicate that
conversion of MDMA to the metabolite 3,4-methylenediox-
yamphetamine (MDA) is significantly higher in male than in
female rats which is probably due to higher activity of
enzymes involved in N-demethylation of MDMA in males
(Fonsart et al., 2008; Hirt et al., 2010). Females apparently are
more exposed to MDMA and males to MDA and consequently
to the metabolite 4-hydroxy-3-methoxyamphetamine (HMA)
(Hirt et al., 2010). Since it has been hypothesized that these
metabolites play a particularly important role in the neuro-
toxicity of the drug this would render male rats more
vulnerable to the 5-HT depleting effects of MDMA which is
not confirmed in our study. The present data do confirm
findings in previous studies that toxic lethality is higher in
males (Fonsart et al., 2008) due to an increased hyperthermia.
Recent evidence in humans supports the existence of a gender
difference in the thermogenic response. Females seem to be
less vulnerable for the induction of a hyperthermic response
by MDMA due to differences in their thermoregulatory
abilities (Wyeth et al., 2009). Considering the fact that MDMA
is metabolizedmore rapidly in males as mentioned above and
the knowledge that the hyperthermic response following
MDMA is positively correlated with 5-HT depletion (Malberg
and Seiden, 1998), it is surprising to see in the present study
that there is no increased 5-HT depletion in males on the long
term which confirms earlier data in rats (Chu et al., 1996).
Human studies even suggest that females might be more
vulnerable to deficiencies in 5-HT functioning after ecstasy
use (Reneman et al., 2001). Our data suggest that with similar
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slightly stronger 5-HT depletion in some brain areas than
males. Sincewith ecstasy consumptionmale and female users
consume similar dosages per pill, females may be exposed to
higher dosages per kilogram body weight since males are in
general heavier than females.
In conclusion,males seem to bemore at risk of developing an
acute, potentially lethal, MDMA-induced hyperthermic response
than females. Our data indicate that 5-HTdepletion inmales and
females with similar hyperthermic responses tends to be
stronger in the female individuals. This supports the hypothesis
that under conditions of a similar thermogenic response females
are more vulnerable to the 5-HT neurotoxicity of MDMA.4. Experimental procedures
4.1. Animals and housing
All experiments have been approved by the animal experi-
ments committee of the University of Groningen. Male and
female wild-type Groningen rats were used. Their ancestors
were originally wild-trapped animals, subsequently bred in
our laboratory for more than 31 generations. Females were
screened for the stage of the estrous cycle they were in. The
rats were in different stages and clearly not synchronized. The
results showed, however, that the magnitude of the standard
deviations in the outcome of the physiological as well as
biochemical data was not different between male and female
animals. This indicates that different stages of the estrous
cycle are not having a major impact on the acute and lasting
effects of MDMA. Room temperature was 21 °C, except during
MDMA administration. Males and females were housed in
separate rooms. All rats were individually housed in clear
Perspex cages (31×15×14 cm) with sawdust bedding in a room
with 12:12 light:dark cycle (lights on at 8:00 h). Food (chow) and
water was available ad libitum throughout the whole
experiment.
4.2. Experiment 1
In the first experiment 45 female and 50 male wild-type
Groningen rats (Rattus norvegicus) of 10 weeks old (bodyweight:
male 370±3.8 g, females 210±2.2 g at the moment of MDMA
injection) were used.
4.2.1. Telemetry
A radio-telemetry system (Data Sciences International, St.
Paul, MN) was used for stress-free monitoring of body
temperature. Fourteen days prior to MDMA administration
transmitters (TA10TA-F40; sensitivity: 0.1 °C) were implanted
intraperitoneally (i.p.) in 28 males and 30 females using O2-
isoflurane anaesthesia. Temperature was measured every
10 min throughout the whole experiment. The cages of the
rats were placed on receiver plates and the signal was
collected and analyzed using the DSI Dataquest® A.R.T.
Acquisition System.
To determine the long-term effect of MDMA on body
temperature, data averages of 12 h (matching the light and
the dark period) were calculated.4.2.2. MDMA/saline injections
3,4-Methylenedioxymethamphetamine (± MDMA-HCl, 99.6%,
obtained from the Dutch Forensic Institute, The Netherlands)
was injected (i.p.) three times with intervals of 3 h (“binge
administration”) during the light phase. The first injectionwas
given 1.5 h after lights went on. MDMA was given to both
females and males at concentrations of 0.3, 1, 3 and 9 mg/kg
MDMA, dissolved in 1 ml ultra purified water. Control animals
were saline injected. Ambient temperature was 25 °C (± 0.5),
starting from 1.5 h before the first injection until 3 h after the
last injection.
4.2.3. Analysis of brain monoamine concentrations
It has been demonstrated that MDMA-induced 5-HT depletion
only occurs when acutely a significant hyperthermic response
is induced (Green et al., 2003). Therefore, long-term effects of
MDMA administration on monoamine concentration in brain
areas were only measured in male and female rats receiving
the high dose of MDMA, i.e., 3×9 mg/kg, since this dose clearly
elicited a hyperthermic response.
Four weeks after treatment thesemale and female rats were
decapitated under brief (30 s) CO2 anesthesia in the early light
phase. From these animals, prefrontal cortex (PFC), striatum,
hippocampus, cerebellum, brainstem (Bregma −8.50 mm to
16 mm), hypothalamus, parietal cortex and septum were
dissected on a chilled plate, immediately snap frozen in liquid
nitrogen and stored at −80 °C. For determination of 5-HT, 5-
HIAA, dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC),
homovanillic acid (HVA) and noradrenalin (NA) in these areas,
high performance liquid chromatography (HPLC) was used. For
this, samples were homogenized in 0.5 ml 0.1 M perchloric acid
and centrifuged at 14000 rpm for 10min at 4 °C. Supernatant
was removed and analyzed for 5-HT, 5-HIAA, DA, DOPAC, and
NA concentrations. For determination of the monoamines and
their metabolites, 100 μl was injected onto a reversed phase
Gemini C18 column (150×4.6 mm, 5 μm particle size), con-
nected to a detector (ESA coulochemmodel 5100A)with a 5011A
detector cell. A difference in potential of 340 mV was set (the
potential of one electrodewas 0 mV and the other was 340 mV).
The mobile phase consisted of 62.7 nM Na2HPO4, 40.0 nM citric
acid, 0.27 mMEDTA, 4.94mMHSA, 10%methanol at pH 4.1with
a flow of 0.5 ml/min. Known amounts of 5-HT, 5-HIAA, DA,
DOPAC, HVA, (Sigma Chemicals) and NA (Research Biochemi-
cals International) were run throughout the whole procedure
for standardization. Monoamine levels were calculated as ng/g
tissue.
4.3. Experiment 2
The second experiment was performed to control for
possible difference in serotonergic depletion between gen-
ders due to a difference in their MDMA-induced hyperther-
mic response. Therefore, in this experiment an additional
group of 10 male rats (body weight 364±8.7 g at the day of
MDMA administration) was injected with a dose of MDMA
that matched the peak temperature response in the female
rats in experiment 1 that received 9 mg/kg MDMA. We chose
to matchmales to the hyperthermic response of females that
received 3×9 mg/kg MDMA in the first experiment, instead of
matching females to the hyperthermic response of males
19B R A I N R E S E A R C H 1 3 9 8 ( 2 0 1 1 ) 1 3 – 2 0that were receiving 3×9 mg/kg MDMA, since a hyperthermic
response of this magnitude apparently holds a high risk of
lethality.
When males were injected with 3×6 mg/kg MDMA the
acute hyperthermic peak response following each injection
appeared to be similar to that in females injected with
3×9 mg/kg MDMA. The timing and methods of implantation
of telemetry transmitters, drug administration and brain
monoamine analysis were all similar as described previously
under experiment 1.
4.4. Statistical analysis
SPSS 14.0 for Windows was employed to analyze the data
statistically. Acute body temperature response (area under the
curve (AUC)) was analyzed using a two-factor ANOVA with
treatment (5 levels) and gender (2 levels) as between-subject
factors. Peak temperatures in the acute body temperature
response were compared using ANOVA with repeated mea-
sures with 3 peaks following the injections (3 levels within
subject) and gender (2-levels) as between-subject factor. The
long-term body temperature was analyzed using repeated-
measurements ANOVAwith treatment (5 levels) and gender (2
levels) as between-subject factors and was tested as the
within-subject repeated measurements factor. In case of
significant main effects, post hoc analyses were performed
using a Bonferroni test to reveal the differences between both
genders for each dose. A one-way ANOVA was used to reveal
for each gender separately the differences between the several
doses.
Lethality rate of males and females for each dose was
statistically analyzed using logistic regression. In experiments
1 and 2, monoamine concentrations were statistically ana-
lyzed using a two-factor ANOVA with treatment (2 levels) and
gender (2 levels) as between-subject factors. In case of a
significant main effect post hoc analysis was performed using
a Bonferroni test to reveal the differences between both
genders for each dose.Acknowledgments
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